Related references
Note: Only part of the references are listed.The Role of the Serum IL-33/sST2 Axis and Inflammatory Cytokines in Chronic Obstructive Pulmonary Disease
Ying Tang et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2014)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease GOLD Executive Summary
Jorgen Vestbo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Evidence for a regulatory loop between IFN- and IL-33 in skin inflammation
Jenny Seltmann et al.
EXPERIMENTAL DERMATOLOGY (2013)
Anti-interleukin-33 inhibits cigarette smoke-induced lung inflammation in mice
Chuan Qiu et al.
IMMUNOLOGY (2013)
Potential autocrine regulation of interleukin-33/ST2 signaling of dendritic cells in allergic inflammation
Z. Su et al.
MUCOSAL IMMUNOLOGY (2013)
Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease
Anna Latiano et al.
PLOS ONE (2013)
Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice
Yasutomo Imai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The Alarmin IL-33 Is a Notch Target in Quiescent Endothelial Cells
Eirik Sundlisaeter et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Serial Monitoring of Soluble Interleukin Family Member ST2 in Patients with Acutely Decompensated Heart Failure
S. Manzano-Fernandez et al.
CARDIOLOGY (2012)
IL-33 regulates TNF-α dependent effects in synovial fibroblasts
Elke Kunisch et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis
Koichi Yanaba et al.
CLINICAL RHEUMATOLOGY (2011)
IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells
Qianting Yang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Expression and Effects of IL-33 and ST2 in Allergic Bronchial Asthma: IL-33 Induces Eotaxin Production in Lung Fibroblasts
Masatsugu Kurokawa et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2011)
Chronic Obstructive Pulmonary Disease 1 New insights into the immunology of chronic obstructive pulmonary disease
Guy G. Brusselle et al.
LANCET (2011)
IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy
Waldiceu A. Verri et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study
T. M. L. Eagan et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
ST2: a novel biomarker for heart failure
Anju Bhardwaj et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2010)
Over-expression of IL-33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice
Zhiguang Xiang et al.
IMMUNOLOGY LETTERS (2010)
Characterization of the Novel ST2/IL-33 System in Patients with Inflammatory Bowel Disease
Carol J. Beltran et al.
INFLAMMATORY BOWEL DISEASES (2010)
Increased IL-33 expression by epithelial cells in bronchial asthma
David Prefontaine et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Increased Levels of Interleukin 33 in Sera and Synovial Fluid from Patients with Active Rheumatoid Arthritis
Yasushi Matsuyama et al.
JOURNAL OF RHEUMATOLOGY (2010)
ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cells
Shinsuke Aoki et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis
Luca Pastorelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus
Mo Yin Mok et al.
RHEUMATOLOGY (2010)
Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma
Xiaojin Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33
Tatjana Pecaric-Petkovic et al.
BLOOD (2009)
Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases
Alexander U. Luethi et al.
IMMUNITY (2009)
Increased Soluble Serum Markers Caspase-Cleaved Cytokeratin-18, Histones, and ST2 Indicate Apoptotic Turnover and Chronic Immune Response in COPD
Stefan Hacker et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2009)
Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells
David Prefontaine et al.
JOURNAL OF IMMUNOLOGY (2009)
Assessing smoking status in children, adolescents and adults: cotinine cut-points revisited
Martin J. Jarvis et al.
ADDICTION (2008)
IL-33 amplifies both Th1-and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells
Molly D. Smithgall et al.
INTERNATIONAL IMMUNOLOGY (2008)
An IL-1 Cytokine Member, IL-33, Induces Human Basophil Activation via Its ST2 Receptor
Maho Suzukawa et al.
JOURNAL OF IMMUNOLOGY (2008)
IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4
Mariola Kurowska-Stolarska et al.
JOURNAL OF IMMUNOLOGY (2008)
The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel 'Alarmin'?
Christine Moussion et al.
PLOS ONE (2008)
IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice
Waldiceu A. Verri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Rarity of TLR4 Asp299Gly and Thr399Ile polymorphisms in the Korean population
Yeun Sun Kim et al.
YONSEI MEDICAL JOURNAL (2008)
Immunology of asthma and chronic obstructive pulmonary disease
Peter J. Barnes
NATURE REVIEWS IMMUNOLOGY (2008)
IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex
Alissa A. Chackerian et al.
JOURNAL OF IMMUNOLOGY (2007)
Differences in local versus systemic TNFα production in COPD:: inhibitory effect of hyaluronan on LPS induced blood cell TNFα release
MA Dentener et al.
THORAX (2006)
Association of the ASP299GLY TLR4 polymorphism with COPD
G Rohde et al.
RESPIRATORY MEDICINE (2006)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome
TRDJ Radstake et al.
ARTHRITIS AND RHEUMATISM (2004)
An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population
E Noguchi et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children
MF Böttcher et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Mediators of chronic obstructive pulmonary disease
PJ Barnes
PHARMACOLOGICAL REVIEWS (2004)
TLR4 Asp299Gly and Thr399Ile polymorphisms are very rare in the Chinese population
JQ Hang et al.
JOURNAL OF ENDOTOXIN RESEARCH (2004)
Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD
D Banerjee et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules
ES Baekkevold et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Neutrophil chemotactic activity of sputum from patients with COPD -: Role of interleukin 8 and leukotriene B4
KM Beeh et al.
CHEST (2003)
Toll-like receptor 4 polymorphisms and atherogenesis
S Kiechl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
NC Arbour et al.
NATURE GENETICS (2000)
Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis
AT Hill et al.
AMERICAN JOURNAL OF MEDICINE (2000)